As my first week representing VIVA! Communications, Australia as part of the GLOBALHealthPR Professional Exchange Program at Spectrum in Washington D.C. draws to a close, my head is spinning with all of the health PR-related information I’ve recently gleaned.
Recent changes to medicinal marijuana laws and regulations globally have expanded opportunities for medical research and patient care.
These actions are part of a broader global movement of governments and advocates to recognise the potential medicinal benefits of marijuana, which has long been considered solely a harmful recreational drug. These purported medical benefits include aiding in the treatment of epilepsy, PTSD, chronic pain and more.
Here we present three examples of GLOBALHealthPR member countries – Australia, Canada and the United States – that are tackling the legislative issues surrounding the use of medical marijuana.
Australia’s (aSPGA’s) “Plea for Life” campaign calls on patients, their families and advocates to post photos on social media of the hashtag #saveaHUSlives. The goal of the campaign is to capture the Australian government’s attention and ultimately get government funding for this drug.
Today we are teaming with the Epilepsy Foundation to release new research coinciding with Purple Day – a global, awareness raising initiative for epilepsy. Already today, the Epilepsy Foundation has raised $100,000 for this worthy cause, and is still counting!
New research released by the Epilepsy Foundation today reveals almost one-in-two Australian adults living with the country’s most common, chronic brain disorder are three-times more likely to experience abnormally high levels of anxiety compared to the general population.